Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI
NCT05820113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109
Last updated 2023-04-19
Summary
The aim of this study was therefore to investigate a new unrolled DL super resolution reconstruction of an initially low-resolution Cartesian T2 turbo spin echo sequence (T2 TSE) and compare it qualitatively and quantitatively to standard high-resolution Cartesian and non-Cartesian T2 TSE sequences in the setting of prostate mpMRI with particular interest in image sharpness, conspicuity of lesions and acquisition time. Furthermore, the investigators assessed the agreement of assigned PI-RADS scores between deep learning super resolution and standard sequences.
Conditions
- Prostate Cancer
- Multiparametric MRI
Interventions
- DEVICE
-
Deep learning based reconstruction of T2-TSE sequence
A newly developed deep-learning based reconstruction of a primarily low-resolved T2-TSE sequence is included in the imaging protocol for evaluation of prostate cancer.
Sponsors & Collaborators
-
Philips Healthcare
collaborator INDUSTRY -
University Hospital, Bonn
lead OTHER
Principal Investigators
-
Julian A Luetkens, PD Dr. med. · University Hospital, Bonn
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2022-11-30
- Completion
- 2022-11-30
Countries
- Germany
Study Locations
More Related Trials
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging
NCT06094322 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach
NCT01138527 ·Status: COMPLETED
-
Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI
NCT00242112 ·Status: COMPLETED ·Phase: NA
-
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT04765150 ·Status: RECRUITING
-
Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer
NCT02618200 ·Status: COMPLETED ·Phase: NA
-
Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI
NCT01857037 ·Status: COMPLETED ·Phase: NA
-
Multimodal Machine Learning Characterization of Solid Tumors
NCT04687969 ·Status: COMPLETED
-
AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
NCT07231627 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer
NCT06820333 ·Status: RECRUITING
-
Novel Imaging in Staging of Primary Prostate Cancer
NCT03537391 ·Status: COMPLETED ·Phase: NA
-
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
NCT02526797 ·Status: ENROLLING_BY_INVITATION
-
Biparametric MRI for Detection of Significant Prostate Cancer
NCT02584179 ·Status: COMPLETED ·Phase: NA
-
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
NCT05384002 ·Status: COMPLETED
-
Dynamic Whole Body PET/ MRI
NCT04495959 ·Status: WITHDRAWN
-
Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
NCT03648359 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147 ·Status: COMPLETED ·Phase: NA
-
NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway
NCT06672926 ·Status: RECRUITING
-
Artificial Intelligence & Prostate Cancer
NCT06298305 ·Status: COMPLETED
-
MRI in Active Surveillance of Prostate Cancer
NCT02326246 ·Status: COMPLETED ·Phase: NA
-
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
NCT06171269 ·Status: RECRUITING ·Phase: NA
-
Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer
NCT05078151 ·Status: UNKNOWN ·Phase: NA
-
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
NCT03180398 ·Status: TERMINATED ·Phase: NA
-
Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
NCT06482489 ·Status: RECRUITING
-
Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging
NCT04993508 ·Status: NOT_YET_RECRUITING ·Phase: NA